CD19

CD19 is a type of protein that in humans is encoded by the CD19 gene. It is a member of the immunoglobulin superfamily and has two immunoglobulin (Ig) domains. The CD19 protein is expressed on the surface of B cells, a type of white blood cell.

Structure

The CD19 protein is a 95 kDa transmembrane glycoprotein that consists of 556 amino acids. It has a large extracellular domain that contains two Ig domains, and a small cytoplasmic domain that contains multiple phosphorylation sites.

Function

CD19 plays a crucial role in establishing intrinsic B cell signaling thresholds through modulating both B cell receptor (BCR)-dependent and independent signaling. It works in conjunction with CD21, CD81, and CD225 in the B cell co-receptor complex. The extracellular domain of CD19 interacts with the B cell receptor, while the cytoplasmic domain interacts with signaling molecules such as phosphatidylinositol 3-kinase (PI3K) and Lyn kinase.

Clinical significance

Alterations in CD19 expression levels or mutations in its gene have been implicated in various diseases. For instance, CD19 is often overexpressed in B cell lymphoma and leukemia, and is a target for various immunotherapies including CAR-T cell therapy. In contrast, CD19 deficiency is associated with hypogammaglobulinemia, a condition characterized by low levels of immunoglobulins and increased susceptibility to infections.

See also

• Cluster of differentiation
• B cell receptor
• Immunoglobulin superfamily

References

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian